secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001528287-25-000021
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace posts Q2 revenue $23.5M (+22% YoY); raises FY2025 revenue and margin guidance
--------------------------------------------------------------------------------

- Revenue grew 22% YoY to $23.5M; RNS System revenue up 16% in Q2.
- Full-year 2025 revenue guidance raised to $94-98M (previous $93-97M).
- Gross margin 77.1% in Q2; FY margin guidance increased to 75-76%.
- Net loss $8.7M vs $7.5M; free cash flow improved to ($2.3M).
- NAUTILUS IGE study missed primary endpoint but showed 79% GTC seizure reduction at 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000152828725000021/0001528287-25-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000152828725000021/npce-20250812.htm
  HTML page:      https://secwatch.observer/filing/0001528287-25-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer